nimorazole has been researched along with Laryngeal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjarnason, NH; Dalhoff, K; Specht, L | 1 |
| Bjarnason, NH; Christiansen, M; Specht, L | 1 |
| Bastholt, L; Berthelsen, A; Hansen, HS; Jørgensen, K; Lindeløv, B; Overgaard, J; Overgaard, M; Specht, L | 1 |
| Ben-Josef, E | 1 |
1 trial(s) available for nimorazole and Laryngeal Neoplasms
| Article | Year |
|---|---|
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
Topics: Adult; Aged; Aged, 80 and over; Cell Hypoxia; Combined Modality Therapy; Double-Blind Method; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Nimorazole; Pharyngeal Neoplasms; Placebos; Radiation-Sensitizing Agents; Salvage Therapy; Treatment Outcome | 1998 |
3 other study(ies) available for nimorazole and Laryngeal Neoplasms
| Article | Year |
|---|---|
Nimorazole may increase the effect of phenprocoumon.
Topics: Aged; Anticoagulants; Antitrichomonal Agents; Blood Coagulation Disorders; Carcinoma, Squamous Cell; Drug Interactions; Hemoptysis; Humans; Laryngeal Neoplasms; Male; Nimorazole; Phenprocoumon | 2005 |
The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists.
Topics: Aged; Aged, 80 and over; Drug Interactions; Female; Fibrinolysis; Glottis; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; International Normalized Ratio; Laryngeal Neoplasms; Male; Nimorazole; Vitamin K | 2008 |
Comment on: A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the the Danish Head and Neck Cancer Study (DAHNCA) Protocol 5-85.
Topics: Humans; Laryngeal Neoplasms; Nimorazole; Pharyngeal Neoplasms; Radiation-Sensitizing Agents | 1998 |